|Download document||Draft concept paper for a guideline on user safety of topically administered products|
|Status||draft: consultation open|
|Consultation start date||24/03/2014|
|Consultation end date||30/06/2014|
|Email address for firstname.lastname@example.org|
This concept paper addresses the need for a specific user safety guideline for topically administered products. The CVMP adopted the revised general User Safety Guideline for pharmaceutical veterinary medicinal products (EMA/CVMP/543/03-Rev.1) in March 2010. This document provides general guidance on how user risk assessment should be conducted and reported. It does not provide specific guidance on how exposure from topically administered products should be assessed.